言語を選択

L1R (MPXV)

L1R (MPXV) 製品リスト

属性
Protein (2)Antibody (1)
製品ライブラリ
オンライン (3)
種
Monkeypox virus (strain Zaire-96-I-16) (1)Mouse (1)Monkeypox virus (Democratic Republic of the Congo) (1)
タグ
His Tag (2)- (1)
マーカー
Unconjugated (3)

製品番号	種	発現システム	製品説明
L1R-M663	Mouse	HEK293	Monoclonal Anti-Monkeypox-L1R Antibody, Human IgG1 (10D8)
L1R-M5241	Monkeypox virus (strain Zaire-96-I-16)	HEK293	Monkeypox virus (strain Zaire-96-I-16) L1R Protein, His Tag (HPLC verified)
L1R-M5243	Monkeypox virus (Democratic Republic of the Congo)	HEK293	Monkeypox virus (Democratic Republic of the Congo) L1R Protein, His Tag (MALS verified)

総数量3

L1R (MPXV)バックグランド

Monkeypox is a rare zoonosis caused by monkeypox virus, which has become the most serious orthpoxvirus and consists of complex double stranded DNA. The pathogenesis of monkeypox is that the virus invades the body from respiratory mucosa, multiplies in lymphocytes, and incurs into blood producing transient venereal toxemia. after the virus multiplies in cells, the cells can invade the blood and propagate to the skin of the whole body, causing lesions. L1R is essential for virus assembly and release.

治験薬に関する情報

英語名	研究コード	研究開発ステージ	会社	適応症	臨床試験
Sifuvirtide	FS-0101; SFT	Phase 2 Clinical	Tianjin Fusogen Pharmaceuticals Inc	HIV Infections; Acquired Immunodeficiency Syndrome	詳細
LP-51	LP-51	Phase 2 Clinical	Institute Of Pathogenic Biology Chinese Academy Of Medical Sciences	HIV Infections; Sjogren's Syndrome	詳細
PGT-121	PGT-121	Phase 2 Clinical	International Aids Vaccine Initiative, Theraclone Sciences Inc, The Scripps Research Institute Inc, The Ragon Institute Of Mgh, Mit And Harvard	HIV Infections; Acquired Immunodeficiency Syndrome; Retroviridae Infections; Sexually Transmitted Diseases, Viral; HIV Seropositivity	詳細
MPER-656 liposome vaccine	MPER-656	Phase 1 Clinical	National Institute Of Allergy And Infectious Diseases (Niaid)	HIV Infections	詳細
Microbicide monoclonal antibody triple combination (Polymun Scientific Immunobiologische Forschung)		Phase 1 Clinical	Polymun Scientific Gmbh	HIV Infections	詳細
Elipovimab	GS-9722	Phase 1 Clinical		HIV Infections	詳細
CPT-31	CPT-31; CPT31-LA	Phase 1 Clinical	Navigen	Purpura, Thrombocytopenic, Idiopathic; HIV Infections	詳細
FB-1002(Frontier Biotechnologies)	FB-1002(前沿生物)	Phase 1 Clinical	Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences	Coronavirus Disease 2019 (COVID-19)	詳細

市販薬剤に関する情報

英語名	研究コード	研究開発ステージ	会社	オリジナル製品名	最初に承認をした国	最初の適応症	最初に承認を受けた会社	承認された日付	適応症	臨床試験
Albuvirtide	FB-006M	Approved		艾可宁	Mainland China	HIV Infections	Frontier Biotechnologies Inc	2018-05-23	Acquired Immunodeficiency Syndrome; HIV Infections	詳細
Enfuvirtide	T-20; R-698; DP-178	Approved	F. Hoffmann-La Roche Ltd	Fuzeon	United States	HIV Infections	F. Hoffmann-La Roche Ltd	2003-03-13	HIV Infections; Acquired Immunodeficiency Syndrome; HIV Seropositivity	詳細